Prognostic Impact of Fibroblast Growth Factor 21 in Patients With Heart Failure
Data from the present study demonstrated the importance of FGF21 as a potential biomarker that may reflect a different pathophysiologic implication from natriuretic peptides.
Authors
- Masaru Obokata (ORCID: https://orcid.org/0000-0002-5473-0688)
- Hideki Ishii (ORCID: https://orcid.org/0000-0003-4348-0123)
- Tatsuya Iso (ORCID: https://orcid.org/0000-0001-5045-1676)
- Keiko Kawai‐Kowase (ORCID: https://orcid.org/0000-0003-1858-5628)
- Masahiko Kurabayashi (ORCID: https://orcid.org/0000-0002-9445-6759)
- Naoki Yuasa
- Kuniko Yoshida
- Kazuki Kagami (ORCID: https://orcid.org/0000-0002-1743-4409)
- Hiroki Matsui (ORCID: https://orcid.org/0000-0003-3243-333X)
- Tomonari Harada (ORCID: https://orcid.org/0000-0003-4662-2991)
- Tomoyuki Yokoyama
- Tsukasa Murakami
- Hiroaki Sunaga
Institutions
- Ashikaga University (JP)
- Gunma University (JP)
- Gunma University of Health and Welfare (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1253/circrep.cr-25-0067
- Citations
- 1
- Primary Topic
- Fibroblast Growth Factor Research
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Japan Agency for Medical Research and Development
- Japanese Circulation Society
- Japan Heart Foundation
- Japan Society for the Promotion of Science